News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
180 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17567)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Biotech Bay
CompactCath Receives CE Mark for its Flagship Discreet Intermittent Urinary Catheter
CompactCath today announced its flagship intermittent urinary catheter has received CE Mark approval as a Class III Medical Device.
December 12, 2017
·
2 min read
Policy
Portola Pharmaceuticals Provides Update on European Marketing Authorization Application for Betrixaban
The CHMP has provided the Day 195 List of Outstanding Issues (LoOI) to the company with a request for responses during the next available submission window of January 23, 2018.
December 12, 2017
·
7 min read
Business
Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors
Mr. Davis joins the organization with over 30 years of experience in leadership and business development, strategic planning and creating joint ventures across the US, Europe and Japan.
December 12, 2017
·
2 min read
Drug Development
Actinium Pharmaceuticals Highlights Promising Data From its AWE Program Featuring a Potent Actinium-225 Labeled Daratumumab Labeled ARC or Antibody Radio-Conjugate Presented at ASH Annual Meeting
Higher cell death observed with Actinium-225 labeled daratumumab with up to ten-fold higher potency as compared to naked daratumuamb.
December 12, 2017
·
9 min read
Business
Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government
This contract award follows the recent approval of Anthrasil by Health Canada under the Extraordinary Use New Drug (EUND) Regulations.
December 12, 2017
·
3 min read
JPK Reports on How Researchers at the Free University of Berlin are Using the NanoWizard ULTRA Speed AFM to Study Carbon-Based Nanoparticles (From Graphene Sheets).
PK Instruments reports on the research of the Eigler Group in the Institute for Chemistry & Biochemistry at the Free University of Berlin.
December 12, 2017
·
2 min read
Drug Development
Cyclacel Announces Presentation of Results From Phase III Seamless Study at ASH Annual Meeting
The study enrolled elderly patients with newly diagnosed AML and compared alternating cycles of decitabine and sapacitabine versus decitabine.
December 12, 2017
·
7 min read
Drug Development
Clementia Initiates Pivotal Phase III MOVE Trial for Palovarotene in Patients With Fibrodysplasia Ossificans Progressiva
Palovarotene, Clementia’s lead product candidate, is a retinoic acid receptor gamma agonist being investigated as a treatment for patients with ultra-rare and debilitating bone diseases.
December 12, 2017
·
8 min read
SGS Introduces GMP DNA Sequencing Service at its Glasgow, UK, Laboratory
The new service, which is available under GMP conditions, is supported by an investment in ABI Life Technologies’ validated 3500xl DNA sequencing technology.
December 12, 2017
·
2 min read
Business
Genedata and Titian Collaborate to Deliver Seamless Flow from Sample Inventory to Data Analysis
Genedata and Titian Software today announced their technology partnership to create an automated, off-the-shelf solution for small molecule and biological inventory management and advanced screening data analysis.
December 12, 2017
·
2 min read
Previous
9 of 18
Next